SYNLAB UK & Ireland:

Modern Slavery & Human Trafficking Statement 2022

Published: 1st August 2022


This is SYNLAB UK and Ireland’s Modern Slavery and Human Trafficking Statement under Section 54 of the UK Modern Slavery Act 2015 for the financial year 2021. Modern slavery is a broad term that encompasses slavery, servitude, forced and compulsory labour and human trafficking. SYNLAB UK&I is part of SYNLAB Group which is committed to the UK Government’s objectives of eradicating modern slavery and human trafficking. The SYNLAB Group is committed to ensuring that the supply chains of its subsidiaries and their business activities are free from ethical and labour standards abuse. This statement summarises the measures that the SYNLAB Group has taken to assess and address the risk of modern slavery in its business and supply chains.

Our Organisational Structure, Business Model & Supply Chain

SYNLAB AG is the ultimate parent company of all the subsidiaries that belong to the SYNLAB Group of companies (SYNLAB) during 2021. SYNLAB AG provides head office support activities to its subsidiaries by way of providing guidelines, advice and assistance, including to SYNLAB UK&I. SYNLAB Bondco PLC is ultimately owned by SYNLAB AG and a non-operational debt issuing vehicle, providing financing to the SYNLAB Group. Our UK operating business activities are carried out by Labco UK Group Limited and its subsidiaries.

We are an international diagnostic service provider. We provide analytical, diagnostical and pathological ser- vices in the field of human and veterinary medicine diagnostic. SYNLAB Group offer services in 36 countries across four continents (Europe, Latin America, Africa and Middle East/Asia), having more than 24,000 employees including 2,700 employees across the UK and Ireland.

In providing our services, we rely on the supply of technical equipment provided by suppliers of analytical machinery and technology for laboratory analyses/diagnostic testing, as well as reagents and chemicals utilised in such testing. Goods and services are provided by professional services companies, subcontractors including couriers and sub-processors of test samples. In addition, we rely on external professional services providers in relation to our head office support, including financing related activities as well as its corporate and financial housekeeping.

Our Policies

We have adopted a Code of Conduct, which was reviewed 2021, setting out our commitment to act ethically and with integrity in all our business relationships. The updated Code of Conduct is currently being re-published within the UK and Ireland, along with new global ‘Speak Up’ reporting arrangements and updated Anti-Bribery, Anti-Corruption and Sanctions Guidelines. In addition, in the UK, we have adopted a dedicated policy on anti-slavery and human trafficking. All our employees must comply with all relevant laws and regulations (including those on modern slavery and human trafficking) and they must respect the personal dignity, rights, and diversity of everyone within and outside SYNLAB.

In 2021 SYNLAB Group developed a Supplier Code of Conduct as part of its plans for Responsible Supply Chain management, which will be implemented in 2022.


To ensure a high level of understanding of the risks of modern slavery and human trafficking in our supply chains and our business, all starting and current employees in the UK have to complete a training module annually on modern slavery and human trafficking.

Due Diligence & Risk Assessment

We acknowledge that slavery and human trafficking exist in many jurisdictions in which we operate, and/or from which we procure goods or services. Our overall objective is to establish and maintain relationships with our suppliers that will minimise the risk that slavery or human trafficking could occur within our supply chains.

Our due diligence approach is based on inclusion of our relevant functional teams, such as legal, compliance, M&A, and procurement. We are continuing to invest in tackling modern slavery by implementing various instruments, including the introduction of MSA provisions in our supplier contracts and the circulation of supplier assessment questionnaires.

To mitigate against the risk of modern slavery and human trafficking in our supply chain, risk assessment and due diligence will continue to focus on our first-tier supplier relationships. It is understood that we need to refine our risk assessment in accordance of our findings. We are taking steps to establish frameworks in which all elements of our supply chain are expected to observe applicable laws and operate in accordance with our Code of Conduct.

We are taking steps to improve our systems and procedures to detect potential modern slavery and human trafficking risks arising around particular products and geographical areas.

SYNLAB AG has a dedicated Compliance Committee, which consists of the Group Chief Executive Officer and Group Chief Financial Officer, chaired by the Group Chief Compliance Officer. The Compliance Committee is supported by Regional Compliance Officers, which includes the Head of Legal and Compliance for the UK and Ireland.

Effective Actions Taken

We use the following key performance indicators to measure how effective we have been to ensure that slavery and human trafficking is not taking place in any part of our business or supply chain:

  • Anti-slavery and human trafficking clauses: We included an anti-slavery and human trafficking clause in our procurement templates. In addition, we are amending existing procurement contracts of our top global first tier supplier to confirm MSA compliance within our supply chain.
  • Training of our employees: We carried out modern slavery and human trafficking training for the vast majority of our employees.
  • CEO Message: Our Group CEO emphasised our social responsibility and ethical principles during regular CEO ‘check-in’ meetings.
  • ESG Initiative: We continued to embed an environmental, social and governance (ESG) initiative both in the UK and across all SYNLAB’s operations globally, aiming to reflect on the most significant ESG risks and opportunities from both SYNLAB and our stakeholders’ perspective. Modern slavery and human trafficking was part of our ESG Report published for 2021.
Looking Ahead

We understand that combating modern slavery and human trafficking is an ongoing imperative. In 2022, we will continue to invest in doing so. Our actions will comprise:

  • Policies: We will implement our Supplier Code of Conduct and re-publish an updated Code of Conduct for all SYNLAB’s workers.
  • Training for our Members: We will continue to raise awareness on modern slavery and human trafficking among our employees.
  • Supplier Questionnaire: We will continue to issue our supplier questionnaire to our suppliers, continuing to ensure that our supply chain complies with our ethical standards set out in our Code of Conduct.

Tom Evans

Director, SYNLAB Limited

For our 2021 Modern Slavery and Human Trafficking Statement please click here.

Latest SYNLAB UK & Ireland News
Important statement: Pathology First

Published: 24th June 2022 We are aware that, in recent days, a media report has been published regarding our Pathology First partnership with Mid and…

Read More (about 'Important statement: Pathology First')
Pathology laboratory becomes the first in the UK to support remote plate reading  

Published: 15th June 2022 A pathology laboratory is leading the way in speeding up access to patient care and treatment after becoming the first in…

Read More (about 'Pathology laboratory becomes the first in the UK to support remote plate reading  ')
SYNLAB ESG Roadmap and Framework

Published: 17th May 2022 Introduction SYNLAB UK&I is thrilled to publish its UK&I ESG Framework and Roadmap, which outlines out how we will achieve our…

Read More (about 'SYNLAB ESG Roadmap and Framework')
Official Notice – Long-haul COVID Testing

Published: 12th March 2022 Update on SYNLAB position re: long-haul COVID testing services in the UK With events unfolding in the last few hours, we…

Read More (about 'Official Notice – Long-haul COVID Testing')
SYNLAB UK & Ireland to showcase biomedical science career opportunities during IBMS Congress

Published: 10th March 2022 Leading pathology provider SYNLAB UK & Ireland is looking forward to welcoming biomedical scientists to its stand at the IBMS Congress…

Read More (about 'SYNLAB UK & Ireland to showcase biomedical science career opportunities during IBMS Congress')
International Day of Women and Girls in Science

Published: 11th February 2022 In celebration of International Day of Women and Girls in Science, we are delighted to unveil a series of short interviews…

Read More (about 'International Day of Women and Girls in Science')
Ground-breaking Veterinary Digital Pathology Service

Published: 28th September 2021 Ground-breaking Veterinary Digital Pathology Service set to Revolutionise Pet Care Across Finland and other Nordic countries A ground-breaking service that enables…

Read More (about 'Ground-breaking Veterinary Digital Pathology Service')
GENDER Pay Gap Report 2020-21

Published: 21st September 2021 A Message From Our CEO Whilst we are pleased at the improvement in our gender pay gap over the past four…

Read More (about 'GENDER Pay Gap Report 2020-21')
Customer Centricity, People and Innovation: The Secret to VPG’s 20 Years’ Success

Published: 1st July 2021 The Veterinary Pathology Group (VPG), a member of SYNLAB UK and Ireland today announced that it is celebrating its 20th anniversary….

Read More (about 'Customer Centricity, People and Innovation: The Secret to VPG’s 20 Years’ Success')
SYNLAB Goes Public

Published: 30th April 2021 We are proud to announce that SYNLAB is now listed on the Frankfurt Stock Exchange. This historical milestone is built on…

Read More (about 'SYNLAB Goes Public')